Nema internetske veze — prikazuje se spremljena verzija stranice.

Equillium Inc

USUSD
← Na Filtar Dionica
US:EQLSE:0A4D

Equillium Inc (US:EQ) — Biotechnology: Pharmaceutical Preparations. Broj burzi na kojima se trguje dionicama tvrtke: 2. Na ovoj stranici — cijena i grafikon, dividende, najveći dioničari i povijest broja dionica.

O Tvrtki

Web-Stranica
equilliumbio.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sjedište
LA JOLLA, United States
Glavni Direktor
Bruce Steel
Zaposlenici
14
Dionice u Optjecaju
63.41 mil. na dan 2026-08-07
Slobodno Prenosive Dionice
36.97 mil.
Tržišna Kapitalizacija
89.41 mil. USD
Insajderi
16%
Institucionalni Ulagači
65.76%
Djelatnost (SIC)
Pharmaceutical Preparations
P/E
gubitak
FCF
−20.1 mil. USD
Dug
7.64 mil. USD
neto novac
Zarada i FCF — za 12 mjeseci do 30.06.2026 (najnovije izvješće tvrtke).
NAV
0.88 USD · P/NAV 1.47
Datum Bilance30.06.2026
Imovina58.7 mil. USD
− Obveze2.65 mil. USD
= NAV (Kapital Dioničara Tvrtke)56.0 mil. USD
= Materijalna NAV56.0 mil. USD
Dionice63 408 082
NAV po Dionici0.88 USD
Opipljivi NAV po Dionici0.88 USD
Cijena Dionice (EQ)1.3000 USD
P/NAV1.47
Povijest NAV-a
Datum BilanceNAVNAV po Dionici
30.06.202656.0 mil. USD0.88 USD
31.03.202659.5 mil. USD0.94 USD
31.12.202528.6 mil. USD0.47 USD
30.09.202530.9 mil. USD0.51 USD
30.06.20255.06 mil. USD0.14 USD
31.03.202510.6 mil. USD0.30 USD
31.12.202419.1 mil. USD0.54 USD
30.09.202423.2 mil. USD0.65 USD
Opis

Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

oglas

Burze i Oznake

BurzaOznakaValutaCijenaVrsta
US USA StocksEQ glavnaUSD1.3 -1.52%obične dionice
LSE London Stock Exchange0A4D IOBUSD1.4 +0.00%obične dionice

Cijena za 3 Mjeseca

dan rasta dan padaPrijeđite mišem / dodirnite dan — cijene otvaranja, zatvaranja, najviša i najniža

Najveći Imatelji

ImateljUdioDioniceDatum Izvješća
Jupiter Topco LLC10.24%6.49 mil.2026-06-30
Decheng Capital LLC7.01%4.45 mil.2026-06-30
Affinity Asset Advisors,…6.47%4.1 mil.2026-06-30
Adar1 Capital Management…5.93%3.76 mil.2026-06-30
Aberdeen Group plc5.73%3.63 mil.2026-06-30
abrdn Life Sciences Inve…5.73%3.63 mil.2026-06-30
Woodline Partners LP5.52%3.5 mil.2026-06-30
RA Capital Management, L…4.88%3.1 mil.2026-06-30
Stempoint Capital LP3.18%2.02 mil.2026-06-30
Vanguard Capital Managem…2.87%1.82 mil.2026-06-30
Eversept Partners, LP2.4%1.52 mil.2026-06-30
VANGUARD INDEX FUNDS-Van…2.21%1.4 mil.2026-06-30
CONNELLY STEPHEN (Presid…≈1.2%762 0252026-06-05
VANGUARD INDEX FUNDS-Van…0.54%344 4892026-06-30
Fidelity Concord Street…0.26%162 8512026-07-31
iShares Trust-iShares Mi…0.24%153 0762026-08-31
American Century ETF Tru…0.12%75 4112026-08-31
ZEDELMAYER CHRISTINE (Ch…≈0.1%62 5862026-06-05
Fidelity Concord Street…0.09%54 6772026-07-31
Fidelity Concord Street…0.07%47 4652026-07-31
Invesco Exch-Trd Fd. TRT…0.06%38 5162026-08-31
Fidelity Concord Street…0.06%36 6832026-07-31
TOM PENNY (Officer)—02026-05-28
KEYES JASON A (Chief Fin…——2025-01-23